Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/12825
Title: | Preoperative Nonsteroidal Anti-inflammatory Drug or Steroid and Outcomes after Trabeculectomy A Randomized Controlled Trial | Authors: | Breusegem, Christophe Spielberg, Leigh Van Ginderdeuren, Rita Vandewalle, Evelien Renier, Charlotte Van de Veire, Sara FIEUWS, Steffen Zeyen, Thierry Stalmans, Ingeborg |
Issue Date: | 2010 | Publisher: | ELSEVIER SCIENCE INC | Source: | OPHTHALMOLOGY, 117(7), p. 1324-1330 | Abstract: | Purpose: To investigate the benefit of preoperative treatment with either topical nonsteroidal anti-inflammatory drug (NSAID) or steroid in terms of clinical outcomes following trabeculectomy. Design: Prospective, randomized placebo-controlled trial. Participants: Sixty-one patients. Methods: Between July 2005 and October 2007, 61 consecutive medically uncontrolled glaucoma patients scheduled for first-time trabeculectomy were randomized to 1 of 3 study topical medication groups: nonsteroidal anti-inflammatory drugs (ketorolac), steroids (fluorometholone), or placebo (artificial tears). Patients instilled 1 drop 4 times daily for 1 month before the procedure and were examined on days 1 and 2, at weeks 1, 2, and 4, and at months 3, 6, 12, 18, and 24 after trabeculectomy. Main Outcome Measures: Incidence of postoperative surgical or medical interventions (needling, laser suture lysis, needling revision, and intraocular pressure [IOP]-lowering medication). Results: Fifty-four patients (54 eyes) were entered for analysis. The mean number of preoperative medications was 2.3 +/- 0.9. The mean baseline IOP was 21.0 +/- 6.0 mmHg. The mean postoperative target IOP was 16.5 +/- 1.8 mmHg. The mean follow-up was 23.6 +/- 4.0 months. The percentage of patients requiring needling within the first year was 41% in the placebo group, 6% in the NSAID, and 5% in the steroid group (P = 0.006). The percentage of patients requiring IOP-lowering medication to reach the target IOP at 1 year was 24% in the placebo group, 18% in the NSAID group, and 0% in the steroid group (P = 0.054 overall; P = 0.038 for steroids vs. others). The log-rank test showed a significant (P = 0.019) difference in medication-free survival curves between the different groups. More specifically, patients in the steroid group needed significantly less medication over the total follow-up (P = 0.007). Conclusions: Topical ketorolac or fluorometholone for 1 month before surgery was associated with improved trabeculectomy outcomes in terms of likelihood of postoperative needling. In the steroid group, there was a significantly reduced need for additional postoperative IOP-lowering medication compared with the other groups. Financial Disclosure( s): The author( s) have no proprietary or commercial interest in any materials discussed in this article. Ophthalmology 2010; 117: 1324-1330 (C) 2010 by the American Academy of Ophthalmology. | Notes: | [Breusegem, C; Spielberg, L; Van Ginderdeuren, R; Vandewalle, E; Renier, C; Van de Veire, S; Zeyen, T; Stalmans, I] Katholieke Univ Leuven Hosp, Dept Ophthalmol, B-3000 Louvain, Belgium. [Van Ginderdeuren, R; Vandewalle, E; Van de Veire, S; Stalmans, I] Catholic Univ Louvain, Lab Ophthalmol, B-3000 Louvain, Belgium. [Fieuws, S] Catholic Univ Louvain, I Biostat, B-3000 Louvain, Belgium. [Fieuws, S] Univ Hasselt, Hasselt, Belgium. | Document URI: | http://hdl.handle.net/1942/12825 | ISSN: | 0161-6420 | e-ISSN: | 1549-4713 | DOI: | 10.1016/j.ophtha.2009.11.038 | ISI #: | 000279436200007 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2011 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
40
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
50
checked on Apr 24, 2024
Page view(s)
30
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.